UPDATE 1-Hikma full-year profit doubles on strong doxycycline sales
March 12, 2014 at 05:21 AM EDT
* Expects injectibles revenue to rise 20 percent this year
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|